$DOCN stock is up 10% today. Here's what we see in our data.

$DOCN stock has now risen 10% today, according to our price data from Polygon. There has been approximately $72,889,370 of trading volume.

$DOCN Insider Trading Activity

$DOCN insiders have traded $DOCN stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $DOCN stock by insiders over the last 6 months:

• BRATIN SAHA (Chief Product & Tech Officer) has made 0 purchases and 4 sales selling 28,214 shares for an estimated $1,041,066.
• MATT STEINFORT (Chief Financial Officer) has made 0 purchases and 2 sales selling 24,996 shares for an estimated $999,840.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$DOCN Hedge Fund Activity

We have seen 137 institutional investors add shares of $DOCN stock to their portfolio, and 167 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• IA VENTURE STRATEGIES FUND II, LP removed 1,480,896 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $59,813,389
• WELLINGTON MANAGEMENT GROUP LLP added 888,185 shares (+42.8%) to their portfolio in Q4 2024, for an estimated $30,260,462
• GOLDMAN SACHS GROUP INC added 599,590 shares (+82.5%) to their portfolio in Q4 2024, for an estimated $20,428,031
• MUBADALA INVESTMENT CO PJSC removed 596,363 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $24,087,101
• SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 544,054 shares (-91.6%) from their portfolio in Q4 2024, for an estimated $18,535,919
• UBS GROUP AG added 533,113 shares (+182.8%) to their portfolio in Q4 2024, for an estimated $18,163,159
• READYSTATE ASSET MANAGEMENT LP added 506,236 shares (+inf%) to their portfolio in Q4 2024, for an estimated $17,247,460

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

You can track data on $DOCN on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.